Literature DB >> 22249442

Gastrointestinal cancer: Combine and conquer.

Rebecca Kirk.   

Abstract

Entities:  

Year:  2012        PMID： 22249442     DOI： 10.1038/nrclinonc.2011.215

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.

Authors:  Hong Yang; Brian Higgins; Kenneth Kolinsky; Kathryn Packman; William D Bradley; Richard J Lee; Kathleen Schostack; Mary Ellen Simcox; Scott Kopetz; David Heimbrook; Brian Lestini; Gideon Bollag; Fei Su
Journal:  Cancer Res       Date:  2011-12-16       Impact factor: 12.701
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.